OmniAb, Inc. (OABI)
4.07
+0.12
(+3.04%)
USD |
NASDAQ |
Sep 11, 16:00
4.01
-0.06
(-1.47%)
After-Hours: 20:00
OmniAb Price : 4.07 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.97 | 4.11 | 3.89 | 4.07 | 1.316M |
| Sep 10, 2026 | 3.922 | 4.075 | 3.91 | 3.95 | 1.394M |
| Sep 09, 2026 | 4.21 | 4.27 | 3.97 | 4.015 | 1.203M |
| Sep 08, 2026 | 4.30 | 4.33 | 4.135 | 4.24 | 1.273M |
| Sep 04, 2026 | 4.78 | 4.78 | 4.28 | 4.33 | 1.704M |
| Sep 03, 2026 | 5.08 | 5.08 | 4.625 | 4.75 | 2.011M |
| Sep 02, 2026 | 4.47 | 5.43 | 4.47 | 5.04 | 5.084M |
| Sep 01, 2026 | 4.35 | 4.45 | 4.32 | 4.44 | 1.156M |
| Aug 31, 2026 | 4.44 | 4.46 | 4.33 | 4.38 | 1.180M |
| Aug 28, 2026 | 4.54 | 4.58 | 4.415 | 4.47 | 1.297M |
| Aug 27, 2026 | 4.81 | 4.81 | 4.56 | 4.61 | 1.283M |
| Aug 26, 2026 | 4.695 | 4.93 | 4.635 | 4.81 | 1.443M |
| Aug 25, 2026 | 4.68 | 4.78 | 4.58 | 4.66 | 1.467M |
| Aug 24, 2026 | 4.40 | 4.71 | 4.20 | 4.71 | 1.941M |
| Aug 21, 2026 | 4.31 | 4.535 | 4.14 | 4.33 | 1.853M |
| Aug 20, 2026 | 4.188 | 4.59 | 4.16 | 4.30 | 2.253M |
| Aug 19, 2026 | 3.95 | 4.19 | 3.83 | 4.19 | 2.872M |
| Aug 18, 2026 | 3.84 | 4.19 | 3.789 | 3.92 | 3.248M |
| Aug 17, 2026 | 4.185 | 4.290 | 3.715 | 3.82 | 18.35M |
| Aug 14, 2026 | 3.40 | 3.45 | 3.30 | 3.38 | 554415.0 |
| Aug 13, 2026 | 3.44 | 3.635 | 3.41 | 3.43 | 922411.0 |
| Aug 12, 2026 | 3.39 | 3.49 | 3.34 | 3.42 | 794029.0 |
| Aug 11, 2026 | 3.33 | 3.545 | 3.295 | 3.38 | 1.191M |
| Aug 10, 2026 | 3.14 | 3.435 | 2.99 | 3.39 | 1.841M |
| Aug 07, 2026 | 2.37 | 3.12 | 2.352 | 3.08 | 2.681M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| IQVIA Holdings, Inc. | 261.77 |
| Champions Oncology, Inc. | 5.10 |
| Medpace Holdings, Inc. | 587.52 |
| Charles River Laboratories International, Inc. | 278.26 |
| Avantor, Inc. | 14.81 |
Price Related Metrics
| PS Ratio | 13.22 |
| Price to Book Value | 2.274 |
| Earnings Yield | -8.86% |
| Market Cap | 591.74M |